Blue Cone Monochromatism (BCM)
A rare inherited retinal condition that affects the function of cone cells, the specialised cells in the retina responsible for colour vision and detailed vision in bright light.
Understanding Blue Cone Monochromatism
Blue Cone Monochromatism (BCM) is a rare inherited retinal condition characterised by impaired function of the cone photoreceptor cells in the retina. Changes in genes involved in cone function mean that the red-sensitive (L-cone) and green-sensitive (M-cone) systems do not function properly, leaving vision largely dependent on blue-sensitive (S-cone) cells and rod cells.
The condition is usually present from birth and can cause reduced visual acuity, severe colour vision impairment, sensitivity to light (photophobia) and involuntary eye movements (nystagmus). Symptoms typically become apparent in early childhood, and vision often remains relatively stable throughout life, although some individuals may experience changes over time.
BCM is a form of inherited cone dysfunction and is sometimes classified as a cone dystrophy. Advances in genetic research, retinal imaging and gene-based therapies are improving understanding of the condition and creating new opportunities for potential treatments.
Retina International works with people affected by BCM, patient organisations, researchers, clinicians and partners worldwide to raise awareness, advance research and ensure patient experiences inform the future of retinal healthcare.
1 in 100,000
Estimated prevalence
2
Associated opsin genes
100%
X-linked inheritance
How Blue Cone Monochromatism can affect vision
Reduced visual acuity
People with BCM often have reduced sharpness of vision, particularly when looking at fine details.
This may affect:
- Reading
- Recognising faces
- Seeing distant objects
Severe colour vision impairment
Because red and green cone function is affected, people with BCM experience significant difficulty distinguishing colours.
Many individuals perceive the world mainly in:
- Blue
- Yellow
- Grey tones
Light sensitivity (photophobia)
Bright light can cause discomfort and reduced visual function.
Many people with BCM prefer:
- Dim lighting
- Sunglasses
- Tinted lenses
Nystagmus
Involuntary eye movements are common, particularly during childhood.
Reduced vision in bright conditions
Unlike typical vision, where daylight improves sight, people with BCM may experience worsening vision in bright environments due to cone dysfunction.
Reduced contrast sensitivity
Some individuals have difficulty distinguishing objects from their background.
Identifying Blue Cone Monochromatism
Eye examination
An ophthalmologist evaluates vision and examines the retina.
Visual acuity testing
Measures clarity of vision.
Colour vision testing
Specialised tests assess colour perception and can identify patterns consistent with BCM.
Optical coherence tomography (OCT)
OCT provides detailed images of retinal layers and can show changes affecting cone cells.
Fundus autofluorescence (FAF)
FAF imaging can help assess retinal health and identify areas of change.
Electroretinography (ERG)
ERG measures electrical responses from retinal cells.
In BCM, specialised ERG testing can demonstrate reduced or absent cone responses.
Genetic testing
Genetic testing can identify changes affecting cone opsin genes and confirm diagnosis.
A genetic diagnosis can help:
- Provide clarity about the condition
- Support family counselling
- Identify eligibility for research studies
- Improve understanding of disease progression
Supporting vision and improving quality of life
Managing light sensitivity
People with BCM may benefit from:
- Tinted glasses
- Light-filtering lenses
- Reduced glare environments
- Adaptive lighting
Low vision support
Support may include:
- Magnification devices
- Digital accessibility tools
- Screen readers
- Vision rehabilitation
Educational support
Children with BCM may benefit from:
- Classroom accommodations
- Accessible learning materials
- Specialist vision support
Workplace support
Adults may benefit from:
- Workplace adjustments
- Assistive technologies
- Flexible approaches to visual tasks
Emerging therapies
Research is exploring treatments aimed at restoring cone function, including:
- Gene therapy
- Gene editing approaches
- Retinal cell therapies
Emotional & Psychological support
Psychological support can help you to cope with the emotional impact of progressive vision loss, build resilience, maintain independence, and improve overall well-being and quality of life.
Supporting independence and quality of life
Living with BCM involves adapting to reduced colour vision, light sensitivity, and reduced visual acuity.
People affected may experience challenges with:
- Education
- Employment
- Driving eligibility
- Navigation
- Daily activities
Support strategies may include:
- Using technology to identify colours
- Adapting lighting environments
- Accessing vision rehabilitation
- Connecting with others living with inherited retinal conditions
Because BCM is present from birth, early support can help children develop effective strategies for learning and independence.
The lived experiences of people with BCM are essential in shaping research priorities and improving support services.
Advancing the future of BCM treatment
Gene therapy
Researchers are investigating whether gene-based approaches can restore functional cone responses.
Potential approaches include:
- Delivering functional copies of affected genes
- Modifying genetic pathways involved in cone development
Retinal cell therapies
Retinal cell therapies explore the replacement or regeneration of damaged retinal cells to help restore visual function.
Retinal prostheses and vision restoration technologies
Retinal prostheses and vision restoration technologies use innovative devices and technologies to stimulate remaining retinal pathways and support vision.
Natural history studies and registries
Long-term studies help researchers understand:
- How vision changes over time
- Which outcomes matter most to patients
- How clinical trials should be designed
Clinical trials
Research studies are exploring new therapies for inherited cone disorders, including BCM.
Information and community support
Take the Next Step
Blue Cone Monochromatism demonstrates the importance of understanding cone biology, genetic causes of vision loss, and patient-centred innovation in inherited retinal disease research.
Through collaboration between people affected by BCM, families, researchers, clinicians, and organisations worldwide, progress continues towards improved diagnosis, better support, and future therapies that may restore or preserve vision.
-
close